• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Occlusion (1984); Pain (1994); Stenosis (2263); Claudication (2550)
Event Date 10/13/2014
Event Type  Injury  
Manufacturer Narrative
Mean age.Majority gender.Event estimated date.The device is not returning for analysis.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The additional supera device is filed under a separate medwatch report number.Attachment: "stenting of femoropopliteal lesions using interwoven nitinol stents".
 
Event Description
It was reported through a research article that the 5.5mm and 6.5mm supera stents may be related to claudication, rest pain, tissue loss (non-healing ulcers and gangrene), restenosis, occlusion, re-intervention including laser atherectomy, percutaneous transluminal angioplasty, additional stent placement, and femoropopliteal bypass.Specific patient information is documented as unknown.Details provided in the attached article titled: " "stenting of femoropopliteal lesions using interwoven nitinol stents".
 
Manufacturer Narrative
D4: the udi# is unknown because the part and lot numbers were not provided.The device was not returned for analysis.The lot history record for this product could not be reviewed because the product was not returned for evaluation and the part and lot numbers were not reported.In this case, there was no reported device malfunction associated with the supera self-expanding stent system (sess).The reported patient effects of worsening claudication, pain, ischemia, restenosis and occlusion are listed in the supera instructions for use as known potential adverse patient effects of peripheral percutaneous intervention.Based on the case information, a conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10005978
MDR Text Key189834552
Report Number2024168-2020-03957
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup,Followup
Report Date 07/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Device Lot NumberUNKNOWN SUPERA
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age64 YR
-
-